Erythrocytes are potential biocompatible carriers for different drugs, peptide molecules and different enzymes. Now a day the method that is used for encapsulation of pharmaceuticals into the erythrocytes mainly based on the hypo-osmotic dialysis. Encapsulation of these drugs or enzymes or peptides into erythrocytes significantly changes the pharmacokinetic properties of drugs in both animals and humans, enhancing liver and spleen uptake and targeting the reticuloendothelial system. By the encapsulation of these into erythrocytes can be applied as targeted drug delivery systems. Erythrocytes are successful as carrier systems for different drugs, enzymes and peptide molecules. The result after using drug encapsulated in erythrocytes is more compared to the free form of the drug.
336 Absract views 4 PDF Downloads 340 Total views
Nanoparticle: An overview of preparation and characterizationSovan Lal Pal, Utpal Jana, P. K. Manna, G. P. Mohanta, R. Manavalan
Studies on the prescriptions of cardio vascular unitsPreeja G. Pillai, P. Suresh, Gayatri Aggarwal, Gaurav Doshi, Vidhi Bhatia, Harsha Kathpalia
Hepatoprotective potential of Andrographis paniculata aqueous leaf extract on ethanol induced liver toxicity in albino ratsA. Sivaraj, P. Vinothkumar, K. Sathiyaraj, S. Sundaresan, K. Devi, B. Senthilkumar